BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32038795)

  • 1. Effects of Oral Rutaecarpine on the Pharmacokinetics of Intravenous Chlorzoxazone in Rats.
    Bista SR; Lee SK; Thapa D; Kang MJ; Seo YM; Kim JH; Kim DH; Jahng Y; Kim JA; Jeong TC
    Toxicol Res; 2008 Sep; 24(3):195-199. PubMed ID: 32038795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
    Chen L; Yang CS
    Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
    Baek HW; Bae SK; Lee MG; Sohn YT
    J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
    Kwon MH; Lee CJ; Cho YY; Kang HE
    J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
    Mizuno D; Tanaka E; Tanno K; Misawa S
    Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
    Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
    Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of cytochrome P450s by rutaecarpine and metabolism of rutaecarpine by cytochrome P450s.
    Lee SK; Kim NH; Lee J; Kim DH; Lee ES; Choi HG; Chang HW; Jahng Y; Jeong TC
    Planta Med; 2004 Aug; 70(8):753-7. PubMed ID: 15326550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
    Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
    Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
    Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
    Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the pharmacokinetics of theophylline by rutaecarpine, an alkaloid of the medicinal herb Evodia rutaecarpa, in rats.
    Ueng YF; Tsai TH; Don MJ; Chen RM; Chen TL
    J Pharm Pharmacol; 2005 Feb; 57(2):227-32. PubMed ID: 15720787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of rutaecarpine on the pharmacokinetics of acetaminophen in rats.
    Lee SK; Bista SR; Jeong H; Kim DH; Kang MJ; Jahng Y; Jeong TC
    Arch Pharm Res; 2007 Dec; 30(12):1629-34. PubMed ID: 18254252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition.
    Kim YG; Cho MK; Kwon JW; Kim SG; Chung SJ; Shim CK; Le Myung G
    Biopharm Drug Dispos; 2002 Apr; 23(3):121-9. PubMed ID: 12173547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of rutaecarpine on the metabolism and urinary excretion of caffeine in rats.
    Noh K; Seo YM; Lee SK; Bista SR; Kang MJ; Jahng Y; Kim E; Kang W; Jeong TC
    Arch Pharm Res; 2011 Jan; 34(1):119-25. PubMed ID: 21468923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
    Shaik IH; Mehvar R
    J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
    Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
    Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
    Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG
    J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
    Tanaka E
    Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of recombinant human growth hormone on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
    Chung W; Kim EJ; Lee I; Kim SG; Lee MG; Kim SH
    Life Sci; 2003 Jun; 73(3):253-63. PubMed ID: 12757833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
    Mehvar R; Vuppugalla R
    J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.